DALLAS, Oct. 7, 2004 (PRIMEZONE) -- TalkingStocks.com announces that Senior Investment Analyst, Jeff Bishop, has issued an investment rating of `Accumulate' for Isonics Corporation (Nasdaq:ISON). Mr. Bishop in the report issued today said, "Isonics appears to be a solid investment at current levels. We feel there has been no material change in the company's fundamentals to warrant the latest price decline. The firm has merely fallen victim to adverse market conditions. In fact, the recent news from the company encourages us that it is still on track to deliver its innovative products."
Bishop adds, "There remains an incredible upside contingent on the company following through with its strategic initiatives. It is highly likely that the Semiconductor or Homeland Security divisions will take this stock to much higher levels. We recommend adding this stock over the next few months in anticipation of a successful product being brought to market in the future."
The full report is available at: http://www.talkingstocks.com/reports/ISON_100704.php
About Isonics Corp.
Isonics Corporation has three business divisions: (1) Isonics Semiconductor, (2) Isonics Life Sciences, and (3) Homeland Defense. Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Through advances in nanotechnology, the Company is also focused on research and development opportunities for further, value-added product and application development. Isonics' Life Sciences division markets and sells stable isotopes for the health care industry such as carbon-13 for diagnostic breath tests and drug design, and radioisotopes and stable isotopes, such as oxygen-18 for positron emission tomography (PET) imaging. Stable isotopes can be thought of as ultra pure materials. This high degree of purification provides enhanced properties as compared to natural materials. Our efforts in the Homeland Security segment are nascent at the present time as we proceed to develop further our neutron-based and other detection technologies. Additional information may be obtained at the Company's Web site at http://www.isonics.com.
About TalkingStocks.com
TalkingStocks.com offers interviews with key executives from publicly traded company. TalkingStocks.com is owned by TalkingStocks.com, LLC. Our services include executive interviews, company profiles, investor calls and our "Ask The CEO" show. To feature your company, please call our Publisher at (972) 731-8621 or email john@talkingstocks.com.
Disclosure: TalkingStocks, LLC has been compensated $3000 for coverage.
Cautionary Statement
Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, and its quarterly report on Form 10-QSB for the nine months ended July 31, 2004, both as filed with the Securities and Exchange Commission, which include the Company's cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities